arrow
P

Pierre-Édouard Debureaux

immuno-hematology department, saint-louis hospital, assistance publique hôpitaux de paris, université paris cité, paris, france
H指数:10
被引数:291

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Relapsed/refractory WAldenström macroglobulinemia patients treated by VEnetoclax with or without anti-CD20 antibody: WAVE a retrospective study of the French CLL/WM group (FILO)

复发/难治性华氏巨球蛋白血症患者采用维奈克拉单抗联合或不联合抗CD20抗体治疗的WAVE研究:法国CLL/WM组(FILO)的回顾性研究

2026-10-020
OAAI
Safety of venetoclax in real-world experience: data from the French national database of pharmacovigilance through all indications in hematological malignancies over 5 years

venetoclax在真实世界经验中的安全性:来自法国全国药物警戒数据库的数据,涵盖5年内血液系统恶性肿瘤的所有适应症。

2025-07-290
OA
Inflammatory Waldenstrom Macroglobulinemia Is Associated with Clonal Hematopoiesis: A Multicentric Cohort

炎症性华氏巨球蛋白血症与克隆性造血相关:一项多中心队列研究

BLOOD
IF23.1
2024-11-050
PRE
Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life study
2023-08-163
OAAI
Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC

急性白血病造血干细胞移植后晚期复发: sfgm-tc的回顾性研究

2023-06-013
OAAI
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses
2020-08-1038
OAAI
Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation
2020-07-3025
OAAI